Buy Ipca Laboratories , says Sudarshan Sukhani of technicaltrends.com.
Sukhani told CNBC-TV18, "Buy Ipca Laboratories. The nice thing is that we have buy idea on these days after seven days of decline because Ipca has bounced back from its earlier lows and yesterday it closed in the green in fact day before it closed in the green, so two days of green for Ipca is good news. It's also suggesting that the lows are holding, so Rs 225 is holding, is turning on the upside."
The company's trailing 12-month (TTM) EPS was at Rs 20.85 per share. (Sep, 2011). The stock's price-to-earnings (P/E) ratio was 12.06. The latest book value of the company is Rs 83.84 per share. At current value, the price-to-book value of the company was 3. The dividend yield of the company was 1.27%.